Shuttle Pharmaceuticals Inc (NASDAQ:SHPH) — Market Cap & Net Worth
Market Cap & Net Worth: Shuttle Pharmaceuticals Inc (SHPH)
Shuttle Pharmaceuticals Inc (NASDAQ:SHPH) has a market capitalization of $1.88 Million ($1.88 Million) as of September 20, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #30176 globally and #6141 in its home market, demonstrating a -9.07% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shuttle Pharmaceuticals Inc's stock price $3.21 by its total outstanding shares 585129 (585.13K). Also see total assets of Shuttle Pharmaceuticals Inc for a full breakdown of the balance sheet.
Shuttle Pharmaceuticals Inc Market Cap History: 2015 to 2026
Shuttle Pharmaceuticals Inc's market capitalization history from 2015 to 2026. Data shows growth from $351.08 to $1.88 Million (127.74% CAGR). Also see Shuttle Pharmaceuticals Inc operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Index Memberships
Shuttle Pharmaceuticals Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.65 Trillion | 0.00% | #884 of 976 |
|
NASDAQ Composite
IXIC
|
$42.00 Trillion | 0.00% | #2816 of 3165 |
Weight: Shuttle Pharmaceuticals Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Shuttle Pharmaceuticals Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shuttle Pharmaceuticals Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Shuttle Pharmaceuticals Inc stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SHPH by Market Capitalization
Companies near Shuttle Pharmaceuticals Inc in the global market cap rankings as of September 20, 2026. Review how tangible is Shuttle Pharmaceuticals Inc's equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Shuttle Pharmaceuticals Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #613 globally with a market cap of $44.92 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.99 Billion USD ( CN¥280.10 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #613 | GALDERMA GROUP AG | NYSE:GALDY | $44.92 Billion | $38.53 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.90 |
| #670 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $40.99 Billion | CN¥43.91 |
Shuttle Pharmaceuticals Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Shuttle Pharmaceuticals Inc's market cap moved from $351.08 to $ 1.88 Million, with a yearly change of 127.74%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.88 Million | +78.33% |
| 2025 | $1.05 Million | +109.55% |
| 2024 | $502.63K | -76.40% |
| 2023 | $2.13 Million | -76.79% |
| 2022 | $9.17 Million | +3919900.00% |
| 2017 | $234.05 | -63.64% |
| 2016 | $643.64 | +83.33% |
| 2015 | $351.08 | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Shuttle Pharmaceuticals Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.88 Million USD |
| MoneyControl | $1.88 Million USD |
| MarketWatch | $1.88 Million USD |
| marketcap.company | $1.88 Million USD |
| Reuters | $1.88 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shuttle Pharmaceuticals Inc
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.